Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review

A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rokuro Morii, Shinji Tsukamoto, Alberto Righi, Kanya Honoki, Yuu Tanaka, Akira Kido, Hiromasa Fujii, Andreas F. Mavrogenis, Yasuhito Tanaka, Costantino Errani
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74267a3d7e8d4412966e9d77119bf92e
record_format dspace
spelling oai:doaj.org-article:74267a3d7e8d4412966e9d77119bf92e2021-11-11T15:30:35ZEffect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review10.3390/cancers132154102072-6694https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5410https://doaj.org/toc/2072-6694A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the mortality associated with wide resection with that of wide resection plus adjuvant chemotherapy for primary and secondary localized malignant GCTB. Among the 745 studies identified, 9 were included. A total of 112 cases of localized malignant GCTB were included, with 39 and 73 cases being primary and secondary malignant GCTB. In primary localized malignant GCTB, the mortality rates were 40% (6/15 patients) and 33% (8/24 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. Overall pooled odds ratio was 1.07 (95% confidence interval, 0.26–4.37; <i>p</i> = 0.92). In secondary localized malignant GCTB, the mortality rates were 30.6% (11/36 patients) and 62.2% (23/37 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. The overall pooled odds ratio was 0.31 (95% confidence interval, 0.10–0.95; <i>p</i> = 0.04). The effect of adjuvant chemotherapy remains unclear for primary localized malignant GCTB, but adjuvant chemotherapy improved the survival of patients with secondary localized malignant GCTB.Rokuro MoriiShinji TsukamotoAlberto RighiKanya HonokiYuu TanakaAkira KidoHiromasa FujiiAndreas F. MavrogenisYasuhito TanakaCostantino ErraniMDPI AGarticlegiant cell tumor of bonelocalizedmalignantadjuvantchemotherapysurgeryNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5410, p 5410 (2021)
institution DOAJ
collection DOAJ
language EN
topic giant cell tumor of bone
localized
malignant
adjuvant
chemotherapy
surgery
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle giant cell tumor of bone
localized
malignant
adjuvant
chemotherapy
surgery
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Rokuro Morii
Shinji Tsukamoto
Alberto Righi
Kanya Honoki
Yuu Tanaka
Akira Kido
Hiromasa Fujii
Andreas F. Mavrogenis
Yasuhito Tanaka
Costantino Errani
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
description A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear. A systematic review was performed to compare the mortality associated with wide resection with that of wide resection plus adjuvant chemotherapy for primary and secondary localized malignant GCTB. Among the 745 studies identified, 9 were included. A total of 112 cases of localized malignant GCTB were included, with 39 and 73 cases being primary and secondary malignant GCTB. In primary localized malignant GCTB, the mortality rates were 40% (6/15 patients) and 33% (8/24 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. Overall pooled odds ratio was 1.07 (95% confidence interval, 0.26–4.37; <i>p</i> = 0.92). In secondary localized malignant GCTB, the mortality rates were 30.6% (11/36 patients) and 62.2% (23/37 patients) in the surgery plus adjuvant chemotherapy and surgery-only groups, respectively. The overall pooled odds ratio was 0.31 (95% confidence interval, 0.10–0.95; <i>p</i> = 0.04). The effect of adjuvant chemotherapy remains unclear for primary localized malignant GCTB, but adjuvant chemotherapy improved the survival of patients with secondary localized malignant GCTB.
format article
author Rokuro Morii
Shinji Tsukamoto
Alberto Righi
Kanya Honoki
Yuu Tanaka
Akira Kido
Hiromasa Fujii
Andreas F. Mavrogenis
Yasuhito Tanaka
Costantino Errani
author_facet Rokuro Morii
Shinji Tsukamoto
Alberto Righi
Kanya Honoki
Yuu Tanaka
Akira Kido
Hiromasa Fujii
Andreas F. Mavrogenis
Yasuhito Tanaka
Costantino Errani
author_sort Rokuro Morii
title Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
title_short Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
title_full Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
title_fullStr Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
title_full_unstemmed Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
title_sort effect of adjuvant chemotherapy on localized malignant giant cell tumor of bone: a systematic review
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/74267a3d7e8d4412966e9d77119bf92e
work_keys_str_mv AT rokuromorii effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT shinjitsukamoto effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT albertorighi effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT kanyahonoki effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT yuutanaka effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT akirakido effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT hiromasafujii effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT andreasfmavrogenis effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT yasuhitotanaka effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
AT costantinoerrani effectofadjuvantchemotherapyonlocalizedmalignantgiantcelltumorofboneasystematicreview
_version_ 1718435245410222080